Sue Ann Latterman , MBA

Stanford, CA

Sue Ann Latterman, VMD has been involved in the healthcare industry for over 18 years. From June of 1985-1989, Dr. Latterman was a practicing veterinarian specializing in equine reproduction and small animal medicine. After getting her MBA in 1990, she began her corporate experience at Hybritech, Inc., a wholly owned subsidiary of Eli Lilly where she focused on new product analysis in cardiology and cancer. In 1993 she became an associate for Mohr Davidow Ventures where she was involved in making investments in First Medical, Fusion Technologies, RITA Medical and AneuRx. In 1995, she was a co-founder of Percusurge, Inc. which was purchased by Medtronic in 2001. Dr. Latterman joined Musket Research Associates (MRA), a boutique investment bank, in 2002 and focuses on investments and private placements in private and smaller capitalization medical device and biotechnology companies. Dr. Latterman has a BA in Biology and a Veterinary Medical Degree (VMD) from the University of Pennsylvania, and an MBA from the Katz Graduate School of Business, University of Pittsburgh.